Training Program in Translational Research

About T32 Training T32 Faculty Members Current Trainees Application Forms and Contacts Translational Research Seminar Series News Contact Information

Training Program in Translational Research Seminar Schedule

All Seminars are on Thursday at 4:00 pm in 4234 Med Sci I unless otherwise noted.

 

5/18/17 Linheng Li, PhD    
  Professor
Department of Pathology & Laboratory Medicine
University of Kansas School of Medicine

4/13/17 Scott Oakes, MD    
  Professor of Pathology
University of California, San Francisco
Targeting the unfolded protein response in pancreatic neuroendocrine tumors – a highly secretory cancer

3/16/17 Ronny Drapkin, MD, PhD    
  Principle Investigator, Department of Obstetrics & Gynecology
Director, Penn Ovarian Cancer Research Center
University of Pennsylvania
Pathogenesis and genomics of ovarian cancer: converging on new therapeutic opportunities

2/9/17 Monique Floer, Cand Med, PhD    
  Assistant Professor
Biochemistry and Molecular Biology
Michigan State University
Chromatin and cell-type specific gene expression in mouse macrophages

1/19/17 Timothy Denning, PhD    
  Associate Professor, Center for Inflammation, Immunity & Infection
Georgia State University, Institute for Biomedical Sciences
Cytokine-mediated regulation of intestinal inflammation: Beauty and the Beast
CVC Danto Auditorium

12/8/16 Joseph Opferman, PhD    
  Associate Member
Department of Cell & Molecular Biology
St. Jude Children’s Research Hospital
Targeting MCL-1 in malignancy

11/3/16 James Musser, MD, PhD    
  Fondren Endowed Presidential Distinguished Chair, Department of Pathology and Genomic Medicine
Director, Center for Molecular and Translational Human Infectious Diseases Research
Houston Methodist Hospital System and Research Institute
Molecular mechanisms underlying pandemics caused by group A Streptococcus, the flesh-eating pathogen

10/6/16 Kevin Mills, PhD    
  Chief Scientific Officer, Cyteir Therapeutics, Inc.
Associate Professor, Tufts Medical School
Tipping the balance: Modulating RAD51 to treat cancer and autoimmune disease

9/29/16 William Petri, MD, PhD    
  Wade Hampton Frost Professor of Epidemiology
Chief, Division of Infectious Diseases and International Health
University of Virginia School of Medicine
Type II mucosal immunity in C. difficile Infection